Partner of Choice
We are the commercialization partner of choice for innovative pharmaceutical and biotech companies seeking business growth in Europe.
Our wholly-owned subsidiaries operate in 19 European countries.
Regions & ContactsOur Value to Partners
35th Anniversary
In celebration of our anniversary, travel through time with us, as we retrace key milestones that have shaped our 35-year history!
Visit TimelineStrategic
Business Areas
As a partner to leading pharmaceutical and biotech companies, we have been bringing innovative specialty pharmaceuticals, orphan drugs, advanced medical technologies and consumer health products to the region for 35 years.
ExploreResponsibility
We comply with the highest quality standards, business ethics, and applicable regulations. Our business is conducted fairly and transparently.
Compliance & EthicsQuality Assurance
We love
what we do
Working at Medis is both fulfilling and exciting. Our passionate, dedicated, and professional team fosters respect and champions diversity, inclusion, and innovation.
Join MedisNews
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
European Commission decision on marketing authorisation is expected in July 2025.
Read More
Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States
Givinostat has already received regulatory approval in the US and UK, with an evaluation ongoing by the European Medicines Agency (EMA).
Read More